Then, hippocampal delivery of AAV9-TRIM11 greatly declined the levels of insoluble/soluble p-tau species and inhibited the formation of neurofibrillary tangles (NFTs)-like tau inclusions/tau-aggregations in PS19 mice, a common mice model mimicking human AD and other tauopathies. The gene discussed is MAPT; the disease is Alzheimer disease.